Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Malignant Melanoma of the Uvea

NCT00872391 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT00872391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00872391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Malignant Melanoma of the Uvea
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2009
Completion date
Not reported
Enrollment
155 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uveal melanoma